Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Esteemed Tutu family honorary guests at first intercontinental symposium
2013-10-08

 

08 October 2013
Photo: Karina Turok

The University of the Free State (UFS) will be hosting a visit by Archbishop Desmond Tutu and Mrs Leah Tutu. The occasion is to launch the Annual Intercontinental Leah Tutu Symposium on rape and violence against women in honour of Mrs Tutu, who has been an outspoken advocate of women’s rights and the sanctity of family life.

The Inaugural Intercontinental Leah Tutu Symposium will take place on:

Thursday 17 October 2013
12:00-14:00
Scaena Theatre


The launch of the Annual Intercontinental Leah Tutu Symposium is organised by Profs Pumla Gobodo-Madikizela (who hosts the Dialogue between Science and Society lecture series) and Heidi Hudson (Director of the Centre for Africa Studies). The Inaugural Intercontinental Leah Tutu Symposium will feature gender and policy analyst Nomboniso Gasa as keynote speaker and Sheila Meintjes, Wits University professor with expertise in gender politics, violence and conflict transformation. The event will also feature voices of survivors of rape and sexual violence, including Johannesburg businesswoman and social entrepreneur, Andy Kawa, who is a survivor of rape and started the organisation Enuf is Enuf to campaign for an end to rape and sexual violence.

On Mrs Tutu’s 80th birthday, during the family’s visit to the UFS, Archbishop Desmond Tutu will also be in conversation with the Vice-Chancellor and Rector, Prof Jonathan Jansen, at a public event: Celebration of a partnership: Archbishop Tutu pays tribute to his wife, on the topic: Man to Man: The Meaning of Leah in My Life.

Thursday 17 October 2013
16:30-18:00
Centenary Complex


The public event is part of the Dialogue between Science and Society lecture series, in collaboration with Mrs Grace Jansen and the Tutu Legacy Foundation.

Please RSVP to Anja Pienaar at pienaaran@ufs.ac.za or +27(0)51 401 7330 or Jo-Anne Naidoo at naidooja@ufs.ac.za or +27(0)51 401 7160.

Two of their daughters, Rev Mpho Tutu and Dr Thandeka Tutu-Gxashe, will accompany Archbishop Desmond and Mrs Leah Tutu.

Short Bio of Mrs Leah Tutu

Nomalizo Leah Tutu is an outspoken advocate for the rights of women and the sanctity of family life. She was awarded an Honorary Doctorate in 2000 by the National Louis University in Atlanta for her commitment to human rights and support of her husband’s work. She is patron of the Phelophepa Train, a health project that brings medical care to people living in remote areas of South Africa. She is also a patron of the Tshwaranang Centre that provides legal advocacy to end violence against women. With Archbishop Tutu, Mrs Tutu is a patron of the Tygerberg Children’s Hospital in Cape Town. She, Archbishop Tutu, and family established the Desmond and Leah Tutu Legacy Foundation in 2012.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept